MyFinsight
Home
Blog
About
Cash and cash
equivalents
$4,425,841
(-31.83%↓ Y/Y)
Prepaid assets and other
current assets
$322,100
(64.42%↑ Y/Y)
Total current assets
$4,747,941
(-29.01%↓ Y/Y)
Deferred offering costs
and other assets
$451,398
(61.02%↑ Y/Y)
Total assets
$5,199,339
(-25.39%↓ Y/Y)
Total liabilities and
stockholders equity
$5,199,339
(-25.39%↓ Y/Y)
Total liabilities
$4,210,187
(-56.25%↓ Y/Y)
Total stockholders
equity
$989,152
(137.27%↑ Y/Y)
Accumulated deficit
-$165,100,085
(-14.14%↓ Y/Y)
Total current
liabilities
$3,805,196
(-58.64%↓ Y/Y)
Total long-term
liabilities
$404,991
(-4.00%↓ Y/Y)
Additional paid-in capital
$166,089,213
(16.97%↑ Y/Y)
Common stock, 0.000001
par value,...
$24
(20.00%↑ Y/Y)
Other accrued
expenses
$2,304,621
(-49.58%↓ Y/Y)
Accounts payable
$1,076,691
(-66.05%↓ Y/Y)
Accrued compensation
$386,741
(-72.14%↓ Y/Y)
Accrued interest,
current
$37,143
(-47.65%↓ Y/Y)
License payable
$404,991
(0.00%↑ Y/Y)
Back
Back
Balance Sheet
ACTUATE THERAPEUTICS, INC. (ACTU)
ACTUATE THERAPEUTICS, INC. (ACTU)
source: myfinsight.com